Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc logo
ARCT

Arcturus Therapeutics Holdings Inc (ARCT)

$17.331.92%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$17.1001
Day's Range
$17.57
$11.7
52-Week Range
$48.75
1 month return24.52%
3 month return17.49%
1 year return55.03%
5 year return149.71%

Company Information

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. is a clinical-stage mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR™ mRNA Technology and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus' diverse pipeline of RNA therapeutic and vaccine candidates includes mRNA vaccine programs for SARS-CoV-2 (COVID-19) and Influenza, and other programs to potentially treat Ornithine Transcarbamylase (OTC) Deficiency, and Cystic Fibrosis along with partnered programs including Glycogen Storage Disease Type 3, Hepatitis B Virus, and non-alcoholic steatohepatitis (NASH). Arcturus' versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, replicon RNA, antisense RNA, microRNA, DNA, and gene editing therapeutics. Arcturus' technologies are covered by its extensive patent portfolio (209 patents and patent applications, issued in the U.S., Europe, Japan, China and other countries). Arcturus' commitment to the development of novel RNA therapeutics has led to collaborations with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, CureVac AG, Synthetic Genomics Inc., Duke-NUS Medical School, and the Cystic Fibrosis Foundation.
OrganizationArcturus Therapeutics Holdings Inc
Employees177
CEOMr. Joseph E. Payne M.Sc.
IndustryHealth Technology

Analyst Recommendation

based on 12 analysts ratings

Buy
58%
Buy
8%
Hold
33%
Sell

Based on 12 Wall street analysts offering stock ratings for Arcturus Therapeutics Holdings Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 156.78%

Current

$17.33

Target

$44.5

Recommendation Trend

Based on 12 analyst

Current1M Ago3M Ago
Buy
7
11
11
Hold
1
4
5
Sell
4
3
2
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
468.1M
Book Value
$5.5
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-7.53
Wall Street Target Price
44.5

Valuation

Trailing PE0.0
Forward PE31.55
Price/Book (mrq)
3.47
Enterprise Value
363.1M
Enterprise Value/Revenue
7.05
Enterprise Value/Ebitda
-2.55

Technicals

Beta
2.51
50 Day MA
16.95
200 Day MA
18.72

Institutional Holdings

Federated Hermes Inc

13.44%

State Street Corporation

10.31%

ARK Investment Management LLC

8.24%

BlackRock Inc

7.4%

Sumitomo Mitsui Trust Holdings Inc

5.51%

Nikko Asset Management Americas Inc

5.51%

Discover more

Frequently Asked Questions

What is Arcturus Therapeutics Holdings Inc share price today?

Can Indians buy Arcturus Therapeutics Holdings Inc shares?

How can I buy Arcturus Therapeutics Holdings Inc shares from India?

Can Fractional shares of Arcturus Therapeutics Holdings Inc be purchased?

What are the documents required to start investing in Arcturus Therapeutics Holdings Inc stocks?

What are today’s High and Low prices of Arcturus Therapeutics Holdings Inc?

What are today’s traded volumes of Arcturus Therapeutics Holdings Inc?

What is today’s market capitalisation of Arcturus Therapeutics Holdings Inc?

What is the 52 Week High and Low Range of Arcturus Therapeutics Holdings Inc?

How much percentage Arcturus Therapeutics Holdings Inc is down from its 52 Week High?

How much percentage Arcturus Therapeutics Holdings Inc is up from its 52 Week low?

What are the historical returns of Arcturus Therapeutics Holdings Inc?

Who is the Chief Executive Officer (CEO) of Arcturus Therapeutics Holdings Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*